Immunovaccine (Canada)

646 papers and 54.7k indexed citations i.

About

In recent decades, authors affiliated with Immunovaccine (Canada) have published 646 papers, which have received a total of 54.7k indexed citations. Scholars at this organization have produced 338 papers in Molecular Biology, 230 papers in Oncology and 106 papers in Cancer Research on the topics of Immunotherapy and Immune Responses (54 papers), Estrogen and related hormone effects (39 papers) and Epigenetics and DNA Methylation (33 papers). Their work is cited by papers focused on Molecular Biology (27.9k citations), Oncology (19.3k citations) and Cancer Research (10.6k citations). Authors at Immunovaccine (Canada) collaborate with scholars in Canada, United States and Russia and have published in prestigious journals including Journal of Clinical Oncology, Journal of Neuroscience and The Journal of Immunology. Some of Immunovaccine (Canada)'s most productive authors include Steven Grant, Darell D. Bigner, Yun Dai, Jeremy N. Rich, Carlos L. Arteaga, Sith Sathornsumetee, Roger E. McLendon, Peter S. Nelson, Ira Tabas and Lale Özcan.

In The Last Decade

Fields of papers published by authors at Immunovaccine (Canada)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Immunovaccine (Canada) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Immunovaccine (Canada) at the time of their publication.

Countries citing scholars working at Immunovaccine (Canada)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Immunovaccine (Canada). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Immunovaccine (Canada) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Immunovaccine (Canada) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Rankless by CCL
2025